SHH and neoplasm: Hh signaling molecules, such as ligands (SHh), receptors (PTCH1) or transcription factors (GLI1/2) in the tumor tissue or body fluid, may reflect tumor progression, metastasis, drug sensitivity or treatment response [3,7,33].